Cyfuse Biomedical K.K.
| Industry | PHARMACEUTICAL |
| Market Segment | Growth |
| Accounting | Japan GAAP |
| Currency | JPY |
| Fiscal Year | 2024 |
Cyfuse Biomedical K.K. engages in the development, manufacture, and sale of regenerative medicine-related products in Japan and the United States. The company develops cellular products for the regenerative medicine and cellular therapy fields; and undertakes various contracts for research cell products. It also offers Bio 3D Printer for use in the regeneration of various tissues and organs, such as cartilage and bones, blood vessels, and nerves; regenova, a bio 3D printer for 3D stacking of cells; and S-PIKE that develops 3D-structures from cells. Cyfuse Biomedical K.K. was incorporated in 20...
Full charting with technical indicators, candlestick, and more.
About Cyfuse Biomedical K.K.
Cyfuse Biomedical K.K. engages in the development, manufacture, and sale of regenerative medicine-related products in Japan and the United States. The company develops cellular products for the regenerative medicine and cellular therapy fields; and undertakes various contracts for research cell products. It also offers Bio 3D Printer for use in the regeneration of various tissues and organs, such as cartilage and bones, blood vessels, and nerves; regenova, a bio 3D printer for 3D stacking of cells; and S-PIKE that develops 3D-structures from cells. Cyfuse Biomedical K.K. was incorporated in 2010 and is headquartered in Minato, Japan.
| Ticker | 4892 |
| Exchange | TSE |
| Sector | Pharmaceutical |
| Industry | PHARMACEUTICAL |